DJO Primed for Growth Heading into 2022

DJO reported 4Q21 orthopedic sales of $155.2 million, +76.5% vs. 4Q20. For the full year 2021, the company generated $466.9 in orthopedic sales, +48.8% vs. 2020. While the outsized growth is attributable to the host of acquisitions DJO made, the company's organic sales still grew in the mid-single digits.

At the end of 1Q21, Colfax will...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us